Arami H, Teeman E, Troksa A et al (2017) Tomographic magnetic particle imaging of cancer targeted nanoparticles. Nanoscale 9:18723–18730
CAS PubMed PubMed Central Article Google Scholar
de Vries EGE, Kist de Ruijter L, Lub-de Hooge MN, Dierckx RA, Elias SG, Oosting SF (2019) Integrating molecular nuclear imaging in clinical research to improve anticancer therapy. Nat Rev Clin Oncol 16:241–255
Kircher MF, de la Zerda A, Jokerst JV et al (2012) A brain tumor molecular imaging strategy using a new triple-modality MRI-photoacoustic-Raman nanoparticle. Nat Med 18:829–834
CAS PubMed PubMed Central Article Google Scholar
Maleszewski JJ, Anavekar NS, Moynihan TJ, Klarich KW (2017) Pathology, imaging, and treatment of cardiac tumours. Nat Rev Cardiol 14:536–549
Park SM, Aalipour A, Vermesh O, Yu JH, Gambhir SS (2017) Towards clinically translatable in vivo nanodiagnostics. Nat Rev Mater 2
Signore A, Mather SJ, Piaggio G, Malviya G, Dierckx RA (2010) Molecular imaging of inflammation/infection: nuclear medicine and optical imaging agents and methods. Chem Rev 110:3112–3145
CAS PubMed Article Google Scholar
Smith BR, Gambhir SS (2017) Nanomaterials for in vivo imaging. Chem Rev 117:901–986
CAS PubMed Article Google Scholar
Yankeelov TE, Abramson RG, Quarles CC (2014) Quantitative multimodality imaging in cancer research and therapy. Nat Rev Clin Oncol 11:670–680
PubMed PubMed Central Article Google Scholar
Yu EY, Bishop M, Zheng B et al (2017) Magnetic particle imaging: a novel in vivo imaging platform for cancer detection. Nano Lett 17:1648–1654
CAS PubMed PubMed Central Article Google Scholar
Lim S, Yoon HY, Jang HJ et al (2019) Dual-modal imaging-guided precise tracking of bioorthogonally labeled mesenchymal stem cells in mouse brain stroke. ACS Nano 13:10991–11007
CAS PubMed Article Google Scholar
Yu GT, Luo MY, Li H et al (2019) Molecular targeting nanoprobes with non-overlap emission in the second near-infrared window for in vivo two-color colocalization of immune cells. ACS Nano 13:12830–12839
CAS PubMed Article Google Scholar
Zheng B, Vazin T, Goodwill PW et al (2015) Magnetic particle imaging tracks the long-term fate of in vivo neural cell implants with high image contrast. Sci Rep 5:14055
PubMed PubMed Central Article Google Scholar
Grippin AJ, Wummer B, Wildes T et al (2019) Dendritic cell-activating magnetic nanoparticles enable early prediction of antitumor response with magnetic resonance imaging. ACS Nano 13:13884–13898
CAS PubMed PubMed Central Article Google Scholar
Antoch G, Freudenberg LS, Beyer T, Bockisch A, Debatin JF (2004) To enhance or not to enhance? 18F-FDG and CT contrast agents in dual-modality 18F-FDG PET/CT. J Nucl Med 45:56S-65S
Bae KT (2010) Intravenous contrast medium administration and scan timing at CT: considerations and approaches. Radiology 256:32–61
Seale MK, Catalano OA, Saini S, Hahn PF, Sahani DV (2009) Hepatobiliary-specific MR contrast agents: role in imaging the liver and biliary tree. Radiographics 29:1725–1748
Beckett KR, Moriarity AK, Langer JM (2015) Safe use of contrast media: what the radiologist needs to know. Radiographics 35:1738–1750
Bogdanov A Jr, Mazzanti ML (2011) Molecular magnetic resonance contrast agents for the detection of cancer: past and present. Semin Oncol 38:42–54
CAS PubMed PubMed Central Article Google Scholar
Pomara C, Pascale N, Maglietta F, Neri M, Riezzo I, Turillazzi E (2015) Use of contrast media in diagnostic imaging: medico-legal considerations. Radiol Med 120:802–809
CAS PubMed PubMed Central Article Google Scholar
Widmark JM (2007) Imaging-related medications: a class overview Proc (Bayl Univ Med Cent) 20:408–417
Herfert K, Mannheim JG, Kuebler L et al (2020) Quantitative rodent brain receptor imaging. Mol Imaging Biol 22:223–244
Serkova NJ, Glunde K, Haney CR et al (2021) Preclinical applications of multi-platform imaging in animal models of cancer. Can Res 81:1189–1200
Weissleder R (2001) A clearer vision for in vivo imaging. Nat Biotechnol 19:316–317
CAS PubMed Article Google Scholar
Wahsner J, Gale EM, Rodriguez-Rodriguez A, Caravan P (2019) Chemistry of MRI contrast agents: current challenges and new frontiers. Chem Rev 119:957–1057
CAS PubMed Article Google Scholar
Song G, Zheng X, Wang Y, Xia X, Chu S, Rao J (2019) A magneto-optical nanoplatform for multimodality imaging of tumors in mice. ACS Nano 13:7750–7758
CAS PubMed Article Google Scholar
Kircher MF, Weissleder R, Josephson L (2004) A dual fluorochrome probe for imaging proteases. Bioconjug Chem 15:242–248
CAS PubMed Article Google Scholar
Townsend DW (2008) Dual-modality imaging: combining anatomy and function. J Nucl Med 49:938–955
Wang Y, Chen J, Yang B et al (2016) In vivo MR and fluorescence dual-modality imaging of atherosclerosis characteristics in mice using profilin-1 targeted magnetic nanoparticles. Theranostics 6:272–286
CAS PubMed PubMed Central Article Google Scholar
Medarova Z, Pham W, Farrar C, Petkova V, Moore A (2007) In vivo imaging of siRNA delivery and silencing in tumors. Nat Med 13:372–377
CAS PubMed Article Google Scholar
Yigit MV, Ghosh SK, Kumar M et al (2013) Context-dependent differences in miR-10b breast oncogenesis can be targeted for the prevention and arrest of lymph node metastasis. Oncogene 32:1530–1538
CAS PubMed Article Google Scholar
Vogel P, Lother S, Ruckert MA et al (2014) MRI Meets MPI: a bimodal MPI-MRI tomograph. IEEE Trans Med Imaging 33:1954–1959
Vogel P, Markert J, Ruckert MA et al (2019) Magnetic particle imaging meets computed tomography: first simultaneous imaging. Sci Rep 9:12627
PubMed PubMed Central Article CAS Google Scholar
Wang G, Chen C, Pai P et al (2019) Intraductal fulvestrant for therapy of ERalpha-positive ductal carcinoma in situ of the breast: a preclinical study. Carcinogenesis 40:903–913
CAS PubMed Article Google Scholar
Brock A, Krause S, Li H, et al. (2014) Silencing HoxA1 by intraductal injection of siRNA lipidoid nanoparticles prevents mammary tumor progression in mice. Sci Transl Med 6:217ra212
Murata S, Kominsky SL, Vali M et al (2006) Ductal access for prevention and therapy of mammary tumors. Can Res 66:638–645
Okugawa H, Yamamoto D, Uemura Y et al (2005) Effect of perductal paclitaxel exposure on the development of MNU-induced mammary carcinoma in female S-D rats. Breast Cancer Res Treat 91:29–34
CAS PubMed Article Google Scholar
Sivaraman L, Gay J, Hilsenbeck SG et al (2002) Effect of selective ablation of proliferating mammary epithelial cells on MNU induced rat mammary tumorigenesis. Breast Cancer Res Treat 73:75–83
CAS PubMed Article Google Scholar
Kenyon E, Westerhuis JJ, Volk M et al (2019) Ductal tree ablation by local delivery of ethanol prevents tumor formation in an aggressive mouse model of breast cancer. Breast Cancer Res 21:129
CAS PubMed PubMed Central Article Google Scholar
Stearns V, Mori T, Jacobs LK, et al. (2011) Preclinical and clinical evaluation of intraductally administered agents in early breast cancer. Sci Transl Med 3:106ra108.
Love SM, Zhang W, Gordon EJ et al (2013) A feasibility study of the intraductal administration of chemotherapy. Cancer Prev Res (Phila) 6:51–58
Chakravarty S, Hix JML, Wiewiora KA et al (2020) Tantalum oxide nanoparticles as versatile contrast agents for X-ray computed tomography. Nanoscale 12:7720–7734
CAS PubMed PubMed Central Article Google Scholar
Hoehn M, Wiedermann D, Justicia C et al (2007) Cell tracking using magnetic resonance imaging. J Physiol 584:25–30
CAS PubMed PubMed Central Article Google Scholar
Foster-Gareau P, Heyn C, Alejski A, Rutt BK (2003) Imaging single mammalian cells with a 1.5 T clinical MRI scanner. Magn Reson Med 49:968–971
留言 (0)